United States · Bill · HR
H.R. 1046 (116th)
Medicare Negotiation and Competitive Licensing Act of 2019
Introduced
7 February 2019
Last action
25 September 2019 · Committee
Status
Subcommittee Hearings Held.
Sponsors
Rep. Doggett, Lloyd [D-TX-37], Sen. Welch, Peter [D-VT], Rep. Cummings, Elijah E. [D-MD-7], Rep. Adams, Alma S. [D-NC-12], Rep. Bass, Karen [D-CA-37], Rep. Beatty, Joyce [D-OH-3], Rep. Blumenauer, Earl [D-OR-3], Rep. Bonamici, Suzanne [D-OR-1], Rep. Cartwright, Matt [D-PA-17], Rep. Case, Ed [D-HI-1], Rep. Casten, Sean [D-IL-6], Rep. Castor, Kathy [D-FL-14], Rep. Castro, Joaquin [D-TX-20], Rep. Chu, Judy [D-CA-28], Rep. Cicilline, David N. [D-RI-1], Rep. Cisneros, Gilbert Ray [D-CA-31], Rep. Clay, Wm. Lacy [D-MO-1], Rep. Cleaver, Emanuel [D-MO-5], Rep. Cohen, Steve [D-TN-9], Rep. Courtney, Joe [D-CT-2], Rep. Crist, Charlie [D-FL-13], Rep. Crow, Jason [D-CO-6], Rep. Davis, Danny K. [D-IL-7], Rep. DeFazio, Peter A. [D-OR-4], Rep. DeLauro, Rosa L. [D-CT-3], Rep. DeSaulnier, Mark [D-CA-10], Rep. Dingell, Debbie [D-MI-6], Rep. Doyle, Michael F. [D-PA-14], Rep. Escobar, Veronica [D-TX-16], Rep. Espaillat, Adriano [D-NY-13], Rep. Evans, Dwight [D-PA-3], Rep. Frankel, Lois [D-FL-22], Sen. Gallego, Ruben [D-AZ], Rep. Garamendi, John [D-CA-8], Rep. Golden, Jared F. [D-ME-2], Rep. Gonzalez, Vicente [D-TX-34], Rep. Green, Al [D-TX-9], Rep. Grijalva, Raúl M. [D-AZ-7], Rep. Haaland, Debra A. [D-NM-1], Rep. Harder, Josh [D-CA-9], Rep. Hastings, Alcee L. [D-FL-20], Rep. Higgins, Brian [D-NY-26], Rep. Hill, Katie [D-CA-25], Rep. Jackson Lee, Sheila [D-TX-18], Rep. Jayapal, Pramila [D-WA-7], Rep. Johnson, Eddie Bernice [D-TX-30], Rep. Kaptur, Marcy [D-OH-9], Rep. Khanna, Ro [D-CA-17]
Subjects
Healthcare
Source updated
5 December 2025
Summary
Medicare Negotiation and Competitive Licensing Act of 2019 This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. (Current law prohibits the CMS from doing so.) The CMS must take certain factors into account during negotiations, including the clinical- and cost-effectiveness of the drug, the financial burden on patients, and unmet patient needs. If the CMS is unable to negotiate the price of a drug, such drug is subject to competitive licensing in order to further its sale under Medicare, notwithstanding existing government-granted exclusivities. Additionally, for one year after a drug is provided under a competitive license, such drug is also subject to specified price limitations; if the drug is not offered at such prices, the drug is subject to additional licensing that furthers its sale under any federal program (e.g., Medicaid).
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
7 February 2019
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
7 February 2019
Introduced
Introduced in House
Source: IntroReferral
7 February 2019
Referred
Referred to the Subcommittee on Health.
Source: Committee
7 February 2019
Introduced
Introduced in House
Source: IntroReferral
8 February 2019
Referred
Referred to the Subcommittee on Health.
Source: Committee
25 September 2019
Committee
Subcommittee Hearings Held.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 7 February 2019 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 7 February 2019
Introduced in House (PDF)
Introduced in House · EN · 7 February 2019
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 7 February 2019
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Doggett, Lloyd [D-TX-37] · D · Sponsor
- Sen. Welch, Peter [D-VT] · D · Sponsor
- Rep. Cummings, Elijah E. [D-MD-7] · D · Sponsor
- Rep. Adams, Alma S. [D-NC-12] · D · Sponsor
- Rep. Bass, Karen [D-CA-37] · D · Sponsor
- Rep. Beatty, Joyce [D-OH-3] · D · Sponsor
- Rep. Blumenauer, Earl [D-OR-3] · D · Sponsor
- Rep. Bonamici, Suzanne [D-OR-1] · D · Sponsor
- Rep. Cartwright, Matt [D-PA-17] · D · Sponsor
- Rep. Case, Ed [D-HI-1] · D · Sponsor
- Rep. Casten, Sean [D-IL-6] · D · Sponsor
- Rep. Castor, Kathy [D-FL-14] · D · Sponsor
- Rep. Castro, Joaquin [D-TX-20] · D · Sponsor
- Rep. Chu, Judy [D-CA-28] · D · Sponsor
- Rep. Cicilline, David N. [D-RI-1] · D · Sponsor
- Rep. Cisneros, Gilbert Ray [D-CA-31] · D · Sponsor
- Rep. Clay, Wm. Lacy [D-MO-1] · D · Sponsor
- Rep. Cleaver, Emanuel [D-MO-5] · D · Sponsor
- Rep. Cohen, Steve [D-TN-9] · D · Sponsor
- Rep. Courtney, Joe [D-CT-2] · D · Sponsor
- Rep. Crist, Charlie [D-FL-13] · D · Sponsor
- Rep. Crow, Jason [D-CO-6] · D · Sponsor
- Rep. Davis, Danny K. [D-IL-7] · D · Sponsor
- Rep. DeFazio, Peter A. [D-OR-4] · D · Sponsor
- Rep. DeLauro, Rosa L. [D-CT-3] · D · Sponsor
- Rep. DeSaulnier, Mark [D-CA-10] · D · Sponsor
- Rep. Dingell, Debbie [D-MI-6] · D · Sponsor
- Rep. Doyle, Michael F. [D-PA-14] · D · Sponsor
- Rep. Escobar, Veronica [D-TX-16] · D · Sponsor
- Rep. Espaillat, Adriano [D-NY-13] · D · Sponsor
- Rep. Evans, Dwight [D-PA-3] · D · Sponsor
- Rep. Frankel, Lois [D-FL-22] · D · Sponsor
- Sen. Gallego, Ruben [D-AZ] · D · Sponsor
- Rep. Garamendi, John [D-CA-8] · D · Sponsor
- Rep. Golden, Jared F. [D-ME-2] · D · Sponsor
- Rep. Gonzalez, Vicente [D-TX-34] · D · Sponsor
- Rep. Green, Al [D-TX-9] · D · Sponsor
- Rep. Grijalva, Raúl M. [D-AZ-7] · D · Sponsor
- Rep. Haaland, Debra A. [D-NM-1] · D · Sponsor
- Rep. Harder, Josh [D-CA-9] · D · Sponsor
- Rep. Hastings, Alcee L. [D-FL-20] · D · Sponsor
- Rep. Higgins, Brian [D-NY-26] · D · Sponsor
- Rep. Hill, Katie [D-CA-25] · D · Sponsor
- Rep. Jackson Lee, Sheila [D-TX-18] · D · Sponsor
- Rep. Jayapal, Pramila [D-WA-7] · D · Sponsor
- Rep. Johnson, Eddie Bernice [D-TX-30] · D · Sponsor
- Rep. Kaptur, Marcy [D-OH-9] · D · Sponsor
- Rep. Khanna, Ro [D-CA-17] · D · Sponsor
Showing 48 of 130 sponsors and actors.
Related records
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/house-bill/1046
- Open data entity: https://api.congress.gov/v3/bill/116/hr/1046
- us · 116-hr-1046 · source updated 5 December 2025